Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

International Nursing Organizations II01:28

International Nursing Organizations II

The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
International Nursing Organizations I01:23

International Nursing Organizations I

International Nursing Organization (ICN) is a global union of national nurses' organizations. Individual nurses can be a part of ICN through member organizations. Each member organization strives to ensure quality nursing care, sound health policies, the advancement of nursing knowledge, respect for the profession, and a satisfied and competent nursing workforce.
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
Vaccinations01:51

Vaccinations

Overview
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SCORE: Serologic evidence of COVID-19 and social and occupational contacts in healthcare workers in long-term care and acute care facilities in Southeastern Ontario (SCORE).

PloS one·2025
Same author

Anti-SARS-CoV-2 Antibody Levels in a Cohort of Health Care Workers Before and After the Omicron Wave in Canada.

Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada·2025
Same author

Inter-cluster contamination: a semivariance analysis of community effect ranges of malaria vector control interventions in a four-armed malaria trial in Muleba, Tanzania.

Malaria journal·2025
Same author

Risk of SARS-CoV-2 infection before and after the Omicron wave in a cohort of healthcare workers in Ontario, Canada.

BMC infectious diseases·2025
Same author

The Strategic Advisory Group of Experts (SAGE) on Immunization-Past, Present and Future.

Vaccines·2025
Same author

Locally acquired typhoid fever outbreak linked to chronic carriage in Ottawa, Canada, 2018-2022.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2024

Related Experiment Video

Updated: Jun 16, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Global immunization policy making processes.

Maggie Bryson1, Philippe Duclos, Ann Jolly

  • 1University of Ottawa, Department of Epidemiology and Community Medicine, 451 Smyth Road, Ottawa, Ontario, Canada.

Health Policy (Amsterdam, Netherlands)
|February 16, 2010
PubMed
Summary
This summary is machine-generated.

Global immunization policy development involves various actors and evidence sources. Key challenges include funding, disease epidemiology data, and stakeholder coordination, with a desire for national Immunization Technical Advisory Groups.

More Related Videos

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
08:13

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

Related Experiment Videos

Last Updated: Jun 16, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
08:13

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

Area of Science:

  • Public Health
  • Health Policy
  • Global Health

Background:

  • National immunization policies are crucial for disease prevention.
  • Understanding policy development processes is essential for improvement.
  • Global perspectives offer insights into diverse challenges and strategies.

Purpose of the Study:

  • To survey global practices in national immunization policy development.
  • To identify key actors, evidence sources, and challenges.
  • To explore desired changes in policy development processes.

Main Methods:

  • Conducted a global survey of countries.
  • Collected data on actors, evidence, challenges, and desired changes.
  • Analyzed reported information on immunization policy development.

Main Results:

  • Most countries utilize or aim to establish national Immunization Technical Advisory Groups (ITAGs).
  • The World Health Organization (WHO) is a highly valued source of information.
  • Common challenges include securing funding, disease data acquisition, and coordinating stakeholders.

Conclusions:

  • Immunization policy development is complex, requiring diverse inputs and addressing significant challenges.
  • Establishing ITAGs is a common goal to strengthen policy processes.
  • Improved funding, data utilization, and coordination are critical for effective immunization policies.